State of vaccine development and what it means for pharma companies

Michael Yee, Jefferies biotech analyst, on what vaccine developments mean to pharma stocks. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Steve Grasso.
06:11
Wed, Sep 9 20205:58 PM EDT